PointState Capital’s Agilon Health AGL Stock Holding History
Bought
Maintained
Sold
Other funds holding AGL
CDR
RSCM
DCP
PointState Capital's AGL Position: Q4 2021 in Review
PointState Capital sold out of Agilon Health (AGL) in Q4 2021, closing a stake of 1,400 shares — an estimated $917K sold.
PointState Capital first reported a position in AGL in Q2 2021 and held it in 2 quarters. The position peaked at $1.62M in Q2 2021. 132 funds tracked by Wall St. Rank hold AGL as of Q4 2021.
- PointState Capital reported no remaining Agilon Health position as of Q4 2021 after selling out during the quarter.
- PointState Capital sold 1,400 Agilon Health shares in Q4 2021, an estimated $917K.
- PointState Capital first reported a position in Agilon Health in Q2 2021 and held it in 2 quarters.
- PointState Capital's Agilon Health position peaked at $1.62M in Q2 2021.
- 132 funds tracked by Wall St. Rank held Agilon Health as of Q4 2021.
Based on PointState Capital's 13F filing for Q4 2021, filed 11 Feb 2022.